CLDX Celldex Therapeutics, Inc.

HealthcareBiotechnology
$33.32
▼ 3.11%
38
QScore Signal
Short
Confidence: MEDIUM
Long-Term
26
Short-Term
49

Value

14
P/E-7.82
8
P/B4.86
45
P/S2704.98
0
EV/EBITDA-10.10
5

Growth

25
Revenue Growth-78.6%
0
EPS Growth-59.2%
39
FCF Growth-33.8%
40

Momentum

80
12-Month Return81.1%
100
3-Month Return47.6%
100
1-Month Return2.8%
58
RSI (14)41.92
50
50/200 MABullish
75

Profitability

20
ROE-50.7%
41
ROA-55.5%
0
Gross Margin98.2%
77
Operating Margin-27397.7%
0
Net Margin-34596.2%
0
FCF Yield-10.1%
0

Risk

41
Beta0.98
90
60-Day Volatility60.2%
0

Generated 5/7/2026, 10:43:07 PM · How is this calculated?

QScore Analysis